Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alere finally bags Axis-Shield with slightly increased offer

This article was originally published in Clinica

Executive Summary

After three months of dogged pursuit, Alere looks to have finally succeeded in its takeover bid for Axis-Shield by sweetening its offer price to 470p per share. The offer may only be 10p more than the original proposal of 460p made in July, and a far cry from the 550p-per-share figure touted by analysts as a reasonable price for the Anglo-Nordic firm, but Axis-Shield's board of directors has given the £235m ($364m) all-cash deal their seal of approval nonetheless.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT097973

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel